Key facts
- Notable investors include Eretz.Bio, FAPESP, Johnson & Johnson Impact Ventures, São Paulo Research Foundation, The Hospital Israelita Albert Einstein — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Phelcom
- ·The full record, as it builds
Funding rounds
No funding rounds for Phelcom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phelcom
Manufacturer of a portable device attached to a smartphone intended to capture precise images of the retina to diagnose eye disease. The company's optical device is designed to light up and image the retina which is connected to the smartphone's camera and an app sends the images over the internet to the cloud which stores and manages patient files, enabling doctors to diagnose remotely through telemedicine.
- Sector
- Healthcare
- HQ
- Sao Carlos, Brazil
- Founded
- 2016
- Employees
- 59
- Website
- phelcom.com/
- Ownership
- Privately Held (backing)
Phelcom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phelcom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phelcom in its N-PORT filings yet. We sweep new filings monthly.